Allows for individualised therapy for a disease that has a wide spectrum of presentation. | Current evidence base involving prospective use of risk scores is weak. |
Removes subjectivity of clinicians from the decision-making process. | Current risk scores fail to capture key prognostic variables and overemphasise on other variables. |
Scores can be modified easily to include future prognostic risk factors using machine learning, maintaining the accuracy of clinical decision-making. | Physicians might find it inconvenient and time-consuming to do a full history to ascertain presence of risk factors. |